Assignee
WILEX AG
DE·28 granted patents·7 pending applications·266 citations·filing 1998–2014
Top patents by PatentIndex Score
35 records- 0192USRE46424EMethod for producing 3-amidinophenylalanine derivativesWILEX AG·Filed 2013·Granted Jun 6, 2017·8 cites·9 claims
- 0292US7884206B2Method for producing 3-amidinophenylalanine derivativesWILEX AG·Filed 2007·Granted Feb 8, 2011·8 cites·19 claims
- 0392US7208521B2Selective inhibitors of the urokinase plasminogen activatorWILEX AG·Filed 2005·Granted Apr 24, 2007·13 cites·38 claims
- 0491US7608623B2Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitorsWILEX AG·Filed 2005·Granted Oct 27, 2009·25 cites·6 claims
- 0589US7691375B2Adjuvant theraphy of G250-expressing tumorsWILEX AG·Filed 2005·Granted Apr 6, 2010·13 cites·18 claims
- 0687US7713980B2Crystalline modifications of N-α-(2,4,6-triisopropyl-phenylsulfonyl)-3-hydroxyamidino-(L)- phenylalanine 4-ethoxycarbonylpiperazide and/or salts thereofWILEX AG·Filed 2005·Granted May 11, 2010·10 cites·19 claims
- 0787US7659396B2Method for the production of phenylalanine derivativesWILEX AG·Filed 2007·Granted Feb 9, 2010·8 cites·4 claims
- 0886US7045504B2Cyclic peptidomimetic urokinase receptor antagonistsWILEX AG·Filed 2004·Granted May 16, 2006·16 cites·6 claims
- 0984US7951943B2Method for preparing and purifying 3-hydroxyamidinophenylalanine compoundsWILEX AG·Filed 2005·Granted May 31, 2011·8 cites·24 claims
- 1084US7807681B2Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitorsWILEX AG·Filed 2008·Granted Oct 5, 2010·8 cites·8 claims
- 1184US7211670B2Method for producing 3-amidinophenylalanine derivativesWILEX AG·Filed 2003·Granted May 1, 2007·15 cites·7 claims
- 1284US7038074B2Arginine mimetics as factor Xa inhibitorsWILEX AG·Filed 2001·Granted May 2, 2006·13 cites·10 claims
- 1382US7049460B1Selective inhibitors of the urokinase plasminogen activatorWILEX AG·Filed 2000·Granted May 23, 2006·13 cites·32 claims
- 1481US7342018B2Urokinase inhibitors and uses thereofWILEX AG·Filed 2003·Granted Mar 11, 2008·18 cites·17 claims
- 1578US7314863B2Cyclic peptidomimetic urokinase receptor antagonistsWILEX AG·Filed 2005·Granted Jan 1, 2008·1 cites·12 claims
- 1677US7538216B2Guanidino phenylalanin compounds used as urokinase inhibitorsWILEX AG·Filed 2003·Granted May 26, 2009·11 cites·15 claims
- 1777US6680320B2Urokinase inhibitorsWILEX AG·Filed 2002·Granted Jan 20, 2004·10 cites·4 claims
- 1876US7157238B2Diagnostic and therapeutic use of antibodies against the urokinase receptorWILEX AG·Filed 2000·Granted Jan 2, 2007·10 cites·6 claims
- 1975US7399468B2Diagnostic and therapeutic use of antibodies against the urokinase receptorWILEX AG·Filed 2006·Granted Jul 15, 2008·2 cites·4 claims
- 2075US7247724B2Method for the production of phenylalanine derivativesWILEX AG·Filed 2003·Granted Jul 24, 2007·8 cites·5 claims
- 2172US6624169B1Urokinase inhibitorsWILEX AG·Filed 1999·Granted Sep 23, 2003·31 cites·14 claims
- 2271US7632496B2Co-administration of cG250 and IL-2 or IFN-α for treating cancer such as renal cell carcinomasWILEX AG·Filed 2003·Granted Dec 15, 2009·4 cites·11 claims
- 2362US7745441B1Urokinase inhibitorsWILEX AG·Filed 1998·Granted Jun 29, 2010·10 cites·6 claims
- 2462US7407751B2Methods for the detection and prognosis of breast tumorsWILEX AG·Filed 2003·Granted Aug 5, 2008·2 cites·11 claims
- 2562US2010068272A1Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitorsWILEX AG·Filed 2009·Application pending·0 cites
- 2651US2006189689A1Arginine mimetics as factor Xa inhibitorsWILEX AG·Filed 2006·Application pending·0 cites
- 2751US2008138275A1Hybridoma cell line G250 and its use for producing monoclonal antibodiesWILEX AG·Filed 2007·Application pending·0 cites
- 2850US2004138110A1Inhibitors of the urokinase receptorWILEX AG·Filed 2004·Application pending·0 cites
- 2948US2005181034A1Formulation of liposomal derivatives of phenylalanineWILEX AG·Filed 2003·Application pending·0 cites
- 3047US6906032B1Cyclic peptidomimetic urokinase receptor antagonistsWILEX AG·Filed 2000·Granted Jun 14, 2005·0 cites·4 claims
- 3146US2004266766A1Selective urokinase inhibitorsWILEX AG·Filed 2004·Application pending·0 cites
- 3243US7951589B2Monoclonal antibodies specific for the chemotactic epitope of the urokinase-type plasminogen activator receptorWILEX AG·Filed 2006·Granted May 31, 2011·0 cites·35 claims
- 3336US10620208B2Classifying a cancer disease using CAIX expressionWILEX AG·Filed 2014·Granted Apr 14, 2020·0 cites·6 claims
- 3432US2004219633A1Method of producing recombinant antibodiesWILEX AG·Filed 2003·Application pending·0 cites
- 3531US6872702B1Inhibitors for urokinase receptorWILEX AG·Filed 1999·Granted Mar 29, 2005·1 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when WILEX AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →